江秀娟,牛继国,呼永华.地塞米松对非小细胞肺癌化疗患者HIF-1α[J].中国肿瘤,2015,24(1):73-75. |
地塞米松对非小细胞肺癌化疗患者HIF-1α |
Effect of Dexamethasone on Level of Hypoxia Inducible Factor-1α and Vascular Endothelial Growth Factor in Patients with Non-small Cell Lung Cancer |
投稿时间:2014-09-04 |
DOI:10.11735/j.issn.1004-0242.2015.01.A016 |
|
 |
中文关键词: 非小细胞肺癌 地塞米松 低氧诱导因子-1α 血管内皮生长因子 |
英文关键词:NSCLC dexamethasone HIF-1α VEGF |
基金项目:甘肃省科技厅技术研究与开发专项计划项目(1105TCYa019) |
|
摘要点击次数: 2664 |
全文下载次数: 1024 |
中文摘要: |
摘 要:[目的] 探讨地塞米松对非小细胞肺癌化疗患者低氧诱导因子-1α(HIF-1α) 和血管内皮生长因子(VEGF)表达的影响。[方法] 97例非小细胞肺癌患者随机分为单纯化疗组和地塞米松辅助化疗组,采用酶联免疫吸附试验(ELISA)分别测定两组患者治疗前及治疗后的血清 HIF-1α、VEGF水平。[结果] 治疗前两组患者HIF-1α及VEGF水平均未见统计学差异(P>0.05);治疗后地塞米松辅助化疗组HIF-1α及VEGF水平明显低于单纯化疗组(P<0.05)。地塞米松辅助化疗组有效率(44.00%)明显高于单纯化疗组(27.79%)(χ2=6.304,P<0.05)。[结论] 地塞米松使非小细胞肺癌患者HIF-1α、VEGF水平下降,提高了化疗近期效果。 |
英文摘要: |
Abstract:[Purpose] To investigate the effect of dexamethasone on level of hypoxia inducible factors-1α(HIF-1α) and vascular endothelial growth factor (VEGF) in chemotherapy of non-small-cell lung cancer( NSCLC ). [Methods] A total of 97 cases with NSCLC were divided into chemotherapy group and combined chemotherapy with dexamethasone . HIF-1α and VEGF level in two groups were detected by enzyme-linked immune sorbent assay in pre - and post-treatment. [Results] The HIF-1α and VEGF level were not significant difference in two groups before treatment(P>0.05). After treatment,the HIF-1α and VEGF level in combined chemotherapy with dexamethasone was lower than that in alone chemotherapy group with significant difference (P<0.05) .The effective rate in combined chemotherapy with dexamethasone was 44.00%,which was higher than that in 27.79% in chemotherapy group(χ2=6.304,P<0.05). [Conclusion] Dexamethasone can decrease the HIF-1α and VEGF level in patients with NSCLC,improved chemotherapy efficacy. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |